Free Trial
NASDAQ:DRTS

Alpha Tau Medical (DRTS) Stock Price, News & Analysis

Alpha Tau Medical logo
$2.28 -0.02 (-0.87%)
(As of 12:13 PM ET)

About Alpha Tau Medical Stock (NASDAQ:DRTS)

Key Stats

Today's Range
$2.20
$2.30
50-Day Range
$2.17
$2.45
52-Week Range
$1.75
$3.40
Volume
39,483 shs
Average Volume
31,225 shs
Market Capitalization
$158.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
48th Percentile Overall Score

DRTS MarketRank™: 

Alpha Tau Medical scored higher than 48% of companies evaluated by MarketBeat, and ranked 611th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alpha Tau Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Alpha Tau Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Alpha Tau Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Alpha Tau Medical are expected to decrease in the coming year, from ($0.48) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alpha Tau Medical is -5.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alpha Tau Medical is -5.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Alpha Tau Medical has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Alpha Tau Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.13% of the float of Alpha Tau Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Alpha Tau Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alpha Tau Medical has recently increased by 30.54%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Alpha Tau Medical does not currently pay a dividend.

  • Dividend Growth

    Alpha Tau Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.13% of the float of Alpha Tau Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Alpha Tau Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alpha Tau Medical has recently increased by 30.54%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Alpha Tau Medical has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Alpha Tau Medical this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Alpha Tau Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.50% of the stock of Alpha Tau Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.65% of the stock of Alpha Tau Medical is held by institutions.

  • Read more about Alpha Tau Medical's insider trading history.
Receive DRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter.

DRTS Stock News Headlines

Alpha Tau transferred with Buy rating at Citi
My #1 Pre IPO Trade for 2025 – NAME and TICKER
One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...
Alpha Tau announces acceptance into FDA’s TPLC TAP Pilot
Alpha Tau Treats First Patient with Recurrent Lung Cancer
See More Headlines

DRTS Stock Analysis - Frequently Asked Questions

Alpha Tau Medical's stock was trading at $3.01 at the beginning of the year. Since then, DRTS shares have decreased by 24.3% and is now trading at $2.28.
View the best growth stocks for 2024 here
.

Alpha Tau Medical Ltd. (NASDAQ:DRTS) issued its earnings results on Monday, May, 20th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.02.

Shares of DRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Tau Medical investors own include Datadog (DDOG), Advanced Micro Devices (AMD), Broadcom (AVGO), Meta Platforms (META), PayPal (PYPL), Sunrun (RUN) and ZIM Integrated Shipping Services (ZIM).

Company Calendar

Last Earnings
5/20/2024
Today
11/21/2024
Next Earnings (Estimated)
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DRTS
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$9.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+248.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-29,160,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.21 per share

Miscellaneous

Free Float
42,151,000
Market Cap
$159.89 million
Optionable
Optionable
Beta
0.77
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:DRTS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners